← FDA Drug Approvals (Drugs@FDA)

EXFORGE HCT

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2009-04-30

Drug application

FDA Application #

NDA022314

Application type

New Drug Application

Brand name

EXFORGE HCT

Generic name

AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE

Active ingredients

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NOVARTIS

Manufacturer

Novartis Pharmaceuticals Corporation

First approval

2009-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown